Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells

Clinical trial NCT04254419 · RECRUITING

Trial details

NCT number: NCT04254419
Sponsor: Nationwide Children's Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

High Grade Glioma

Start date: 2025-03-04
Primary completion: 2030-12-31
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.